Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    "progressive myoclonus epilepsy with ataxia" OR "Myoclonic Epilepsies, Progressive"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Enrolling by invitation Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg Type
Condition: Unverricht-Lundborg Syndrome
Intervention: Drug: Ropinirole
2 Completed
Has Results
Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults
Condition: Unverricht-Lundborg Disease
Interventions: Other: Placebo;   Drug: BRV 2.5 mg;   Drug: BRV 25 mg;   Drug: BRV 50 mg
3 Completed Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults
Condition: Unverricht-Lundborg Disease
Interventions: Drug: Brivaracetam 25 mg;   Drug: Brivaracetam 50 mg;   Other: Placebo
4 Recruiting Genetic Characterization of Movement Disorders and Dementias
Conditions: Ataxia;   Dystonia;   Parkinson's Disease;   Amyotrophic Lateral Sclerosis;   Corticobasal Degeneration;   Multiple System Atrophy;   Alzheimer's Disease;   Lewy Body Dementia;   Parkinson Disease-Dementia;   Dentatorubral-pallidoluysian Atrophy;   Creutzfeldt-Jakob Disease and Fatal Familial Insomnia;   Fragile X-associated Tremor/Ataxia Syndrome;   Krabbe's Disease;   Niemann-Pick Disease, Type C;   Neuronal Ceroid Lipofuscinosis
Intervention:
5 Completed Ketogenic Diet in Lafora Disease
Condition: Lafora Disease
Intervention:
6 Completed Clinical and Genetic Studies of Familial Presenile Dementia With Neuronal Inclusion Bodies
Conditions: Familial Dementia With Neuroserpin Inclusion Bodies;   Nervous System Heredodegenerative Disorder
Intervention:

Study has passed its completion date and status has not been verified in more than two years.